Basel, Switzerland

Robert James Weikert

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Basel, CH (2016 - 2018)
  • Clifton, NJ (US) (2016 - 2018)

Company Filing History:


Years Active: 2016-2018

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):

Title: The Innovative Contributions of Robert James Weikert

Introduction

Robert James Weikert is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of antiviral compounds, particularly in the treatment and prophylaxis of hepatitis B virus infection. With a total of 10 patents to his name, Weikert's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Weikert's latest patents include groundbreaking inventions such as "Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection." This invention provides novel compounds characterized by a specific general formula, which includes various defined variables. Additionally, he has developed antiviral compounds, disclosed in his patent titled "Antiviral compounds." This patent reveals compounds of Formula I, along with pharmaceutical compositions and methods for their use in preventing or treating HCV infection.

Career Highlights

Throughout his career, Weikert has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to contribute to significant advancements in antiviral therapies.

Collaborations

Weikert has collaborated with esteemed colleagues such as Elbert Chin and Qingjie Ding. These partnerships have further enriched his research and development efforts in the field of antiviral compounds.

Conclusion

Robert James Weikert's innovative work and numerous patents highlight his dedication to advancing antiviral therapies. His contributions continue to influence the pharmaceutical landscape, making a lasting impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…